The innovative drug concept continued to be strong in early trading. Baihua Pharmaceutical had 3 consecutive sales, while Rongchang Biotech, Smart Pharmaceuticals, Wanbang Pharmaceuticals, BeiGene Shenzhou, Xinjiangjiang, and Sanyuan Gene had higher gains.

Zhitongcaijing · 2d ago
The innovative drug concept continued to be strong in early trading. Baihua Pharmaceutical had 3 consecutive sales, while Rongchang Biotech, Smart Pharmaceuticals, Wanbang Pharmaceuticals, BeiGene Shenzhou, Xinjiangjiang, and Sanyuan Gene had higher gains.